Stocktoria
Terumo Corporation 4543.T
Terumo Corporation (4543.T) earns a Piotroski F-score of 5/9 (mixed financial health), with an Altman Z″ in the safe zone. It pays a dividend yielding 1.30% (safety: safe). FY2026 revenue was ¥1.13T at a 12.0% net margin.
Price from month-end closes (Yahoo) — for reference, not real-time.
How it ranks in Healthcare · percentile among 46 companies
Percentile vs other Healthcare companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 5/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · safe zone
| Component | Value |
|---|---|
| Working capital / assets | 0.139 |
| Retained earnings / assets | 0.483 |
| EBIT / assets | 0.076 |
| Equity / liabilities | 2.177 |
FAQ
Is 4543.T financially healthy?
Terumo Corporation's Piotroski F-score is 5/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.
Does 4543.T pay a dividend, and is it safe?
Yes. Terumo Corporation pays a dividend yielding about 1.30% with a 30.4% payout ratio, rated “safe” for safety.
How profitable is 4543.T?
In FY2026, Terumo Corporation had a net margin of 12.0% and a return on equity of 8.6%.
Source: company filings via Yahoo Finance · JP · as of 2026-03-31. Figures in JPY; non-US fundamentals are aggregated by Yahoo (shorter history); facts plus Stocktoria's own computed scores — not investment advice.